about
Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferationPoly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studiesPolyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.Nanoparticle-aptamer bioconjugates for cancer targeting.Nanostructured materials for applications in drug delivery and tissue engineering.Use of degradable and nondegradable nanomaterials for controlled release.Nanoparticulate systems for polynucleotide delivery.Characterization of nanoparticles for therapeutics.Synergistic effects of mutations and nanoparticle templating in the self-assembly of cowpea chlorotic mottle virus capsids.Nanoscale particle therapies for wounds and ulcers.Gene Therapy for Cartilage Repair.Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery.Nanotechnology applied to treatment of mucopolysaccharidoses.Physicochemical properties of polymers: An important system to overcome the cell barriers in gene transfection.Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery.Nanoparticle therapeutics: a personal perspective.Nanomedicine--prospective therapeutic and diagnostic applications.Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.Peptide-based cationic molecules for the production of positive charged liposomes and micelles
P2860
Q27310684-08076199-E5CD-457F-AC51-EBAB9A018C6DQ34312572-1ADCCBB2-FB55-44B7-A8B1-1C9F0293BB41Q34982118-8544C77D-9E24-450F-9754-93E780C78371Q36460842-2AB30259-9DBF-4A42-AEE4-A017D9EDA260Q36807625-DA1632CF-5035-4D19-89B7-4C945BB35E27Q36917951-11A3CF9C-AC3A-4DDB-9E43-F3D8CEDE83FEQ37004107-DBA70EB4-724D-4F3C-8019-F86F2886695CQ37038821-A0964FBF-ABBB-491C-B4DF-1FCAF6AF5118Q37365877-854580B0-DB83-4EC5-92D6-17FF55B9EE30Q37763155-3595EB3D-AB18-46A5-8390-3ACB1BAABD38Q38526206-60DED6B8-571F-4997-B09E-8E9A8E529412Q38813247-48FD8ADB-CF3B-4B99-AFD3-16CC701C8ED0Q38850942-3F169708-563F-4DAE-902B-F032ED4892FDQ42155678-88435F3E-6F39-462B-8BE5-966948BEFD37Q42919601-A00E7426-BA37-4B9E-AFD2-B95FE1A7261CQ48827574-8E834C3A-EB46-4220-AA89-F7175476AA19Q51540815-E7EC0A09-9752-4FD7-B9E3-8E1487DEEFB3Q52589516-5689095E-7997-4EB8-AA18-4A55227ACB00Q57084417-5E7BE4E4-8B6E-462B-B2D3-1F899B1D5BF6
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nanoparticle-mediated gene delivery: state of the art.
@ast
Nanoparticle-mediated gene delivery: state of the art.
@en
type
label
Nanoparticle-mediated gene delivery: state of the art.
@ast
Nanoparticle-mediated gene delivery: state of the art.
@en
prefLabel
Nanoparticle-mediated gene delivery: state of the art.
@ast
Nanoparticle-mediated gene delivery: state of the art.
@en
P2093
P2860
P1476
Nanoparticle-mediated gene delivery: state of the art.
@en
P2093
Gary Hellermann
M Ravi Kumar
Richard F Lockey
Shyam S Mohapatra
P2860
P304
P356
10.1517/14712598.4.8.1213
P407
P577
2004-08-01T00:00:00Z